Llorente & Cuenca, S.A. (BME:LLYC)
5.80
-0.15 (-2.52%)
Mar 18, 2026, 5:35 PM CET
Llorente & Cuenca Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 114.65 | 115.15 | 96.72 | 89.48 | 64.15 | 44.71 |
Other Revenue | 2.75 | 2.53 | 1.3 | 0.8 | - | - |
| 117.4 | 117.67 | 98.02 | 90.28 | 64.15 | 44.71 | |
Revenue Growth (YoY) | 0.52% | 20.05% | 8.57% | 40.74% | 43.48% | -7.17% |
Cost of Revenue | 66.72 | 63.94 | 51.56 | 46.52 | 31.97 | 24.64 |
Gross Profit | 50.68 | 53.73 | 46.45 | 43.76 | 32.18 | 20.07 |
Selling, General & Admin | 31.42 | 34.63 | 27.97 | 26.92 | 18.33 | 10.36 |
Other Operating Expenses | 3.54 | 3.6 | 1.39 | 1.52 | 2.27 | 0.98 |
Operating Expenses | 41.89 | 45.43 | 33.06 | 31.83 | 23.64 | 14.25 |
Operating Income | 8.79 | 8.31 | 13.4 | 11.94 | 8.54 | 5.82 |
Interest Expense | -2.43 | -2.2 | -1.28 | -0.81 | -0.41 | -0.23 |
Interest & Investment Income | 10.63 | 2.95 | 0.64 | 0.12 | 0.04 | 0.04 |
Currency Exchange Gain (Loss) | 0.3 | 0.61 | -1.09 | -0.22 | 0.02 | -0.39 |
Other Non Operating Income (Expenses) | 0.26 | -0.9 | -0.21 | -0.34 | -0.2 | -0.1 |
EBT Excluding Unusual Items | 17.55 | 8.77 | 11.46 | 10.69 | 7.98 | 5.14 |
Impairment of Goodwill | - | - | -0.43 | -0.19 | - | - |
Gain (Loss) on Sale of Investments | 0.42 | -0.17 | 0.04 | -0.13 | - | - |
Asset Writedown | 0.02 | -0 | -0.02 | -0.07 | -0.05 | -0.01 |
Pretax Income | 17.99 | 8.6 | 11.05 | 10.3 | 7.93 | 5.14 |
Income Tax Expense | 2.14 | 2.28 | 3.25 | 2.92 | 2.41 | 2.19 |
Earnings From Continuing Operations | 15.85 | 6.32 | 7.8 | 7.38 | 5.52 | 2.95 |
Earnings From Discontinued Operations | -0.71 | 2.73 | 1.37 | - | - | - |
Net Income to Company | 15.14 | 9.05 | 9.17 | 7.38 | 5.52 | 2.95 |
Minority Interest in Earnings | 0.02 | -0.1 | -0.83 | -0.43 | -0.19 | -0.68 |
Net Income | 15.17 | 8.95 | 8.34 | 6.96 | 5.33 | 2.27 |
Net Income to Common | 15.17 | 8.95 | 8.34 | 6.96 | 5.33 | 2.27 |
Net Income Growth | 298.77% | 7.28% | 19.93% | 30.58% | 134.58% | -31.66% |
Shares Outstanding (Basic) | 11 | 11 | 12 | 12 | 12 | 0 |
Shares Outstanding (Diluted) | 11 | 11 | 12 | 12 | 12 | 0 |
Shares Change (YoY) | -3.59% | -2.39% | - | -0.10% | 3128.31% | -4.00% |
EPS (Basic) | 1.35 | 0.79 | 0.72 | 0.60 | 0.46 | 6.30 |
EPS (Diluted) | 1.35 | 0.79 | 0.72 | 0.60 | 0.46 | 6.30 |
EPS Growth | 313.60% | 9.91% | 19.93% | 30.71% | -92.73% | -28.81% |
Free Cash Flow | 25.07 | 9.03 | 10.32 | 1.89 | 11.57 | 7.34 |
Free Cash Flow Per Share | 2.24 | 0.80 | 0.89 | 0.16 | 0.99 | 20.34 |
Gross Margin | 43.17% | 45.66% | 47.39% | 48.47% | 50.17% | 44.89% |
Operating Margin | 7.49% | 7.06% | 13.67% | 13.22% | 13.31% | 13.02% |
Profit Margin | 12.92% | 7.61% | 8.51% | 7.71% | 8.30% | 5.08% |
Free Cash Flow Margin | 21.36% | 7.67% | 10.53% | 2.09% | 18.03% | 16.41% |
EBITDA | 13.63 | 13.52 | 16.44 | 15.13 | 10.99 | 8.04 |
EBITDA Margin | 11.61% | 11.49% | 16.77% | 16.76% | 17.13% | 17.99% |
D&A For EBITDA | 4.84 | 5.21 | 3.04 | 3.19 | 2.45 | 2.22 |
EBIT | 8.79 | 8.31 | 13.4 | 11.94 | 8.54 | 5.82 |
EBIT Margin | 7.49% | 7.06% | 13.67% | 13.22% | 13.31% | 13.02% |
Effective Tax Rate | 11.90% | 26.46% | 29.40% | 28.34% | 30.39% | 42.54% |
Revenue as Reported | 117.4 | 117.67 | 98.03 | 90.29 | 64.15 | 44.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.